Recorded fact · drug.label_indication
drug.label_indication for umeclidinium-bromide|chronic-obstructive-pulmonary-disease
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 9d6615f5 resolves to.
The record
| Fact id | 9d6615f57f7465f3d3bdd829 |
|---|---|
| Entity | drug: umeclidinium-bromide|chronic-obstructive-pulmonary-disease |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20251106 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Umeclidinium ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 33c5c7e271369ebaa6a89c4d979f150509d2ddf1785d45c8f6e540356a575228.
The value
{
"ingredient": "Umeclidinium Bromide",
"conditionId": "chronic-obstructive-pulmonary-disease",
"conditionName": "Chronic obstructive pulmonary disease",
"matchedAlias": "chronic obstructive pulmonary disease",
"context": "indication",
"brand": "Umeclidinium Ellipta",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "763388a5-cc89-4c25-8562-521df679b7e8",
"labelEffectiveTime": "20251106",
"labelsRead": 2,
"labelsNaming": 2,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 3b848c1ab86d6675f49bab55694fd3079c9f7387d1bdb513afa92c3e09dc5137.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.